ISCHEMIA 试验:PCI 与 CABG 的健康状态结局
基于 ISCHEMIA 试验的事后分析,比较保守治疗(n=2232)、PCI(n=1198)和 CABG(n=340)患者的健康状态。结果显示,PCI 和 CABG 在 1 年和 3 年时的健康状态均优于保守治疗,CABG 在 1 年时心绞痛缓解优于 PCI,但 3 年时两者无差异。
要点
- PCI 和 CABG 在 1 年和 3 年时的健康状态均优于保守治疗。
- CABG 在 1 年时心绞痛缓解优于 PCI,但 3 年时无差异。
- 3 年时 PCI 与 CABG 在健康状态评分上无显著差异。
核心结论
- 在 ISCHEMIA 试验中,PCI 和 CABG 在 3 年时的健康状态均优于保守治疗。
- CABG 在 1 年时心绞痛缓解优于 PCI,但 3 年时无差异。
研究设计与样本
- ISCHEMIA 试验的事后分析,比较保守治疗(n=2232)、PCI(n=1198)和 CABG(n=340)患者的健康状态结局。
- 主要结局为西雅图心绞痛问卷-7 总结评分(SAQ-SS)和心绞痛频率评分(SAQ-AF),评分越高表示健康状态越好。
- 采用比例优势模型比较 1 年和 3 年结局,并调整人口学、临床和血管造影特征。
主要发现
- 保守治疗、PCI 和 CABG 组的 SAQ-SS 在 1 年时分别增加 9.9±18.1、15.7±19.3 和 16.1±19.1 分,3 年时分别增加 11.5±20.2、16.5±21.8 和 15.0±19.4 分。
- 保守治疗、PCI 和 CABG 组无心绞痛的比例在 1 年时分别为 61.4%、73.3% 和 82.4%,3 年时分别为 70.4%、76.1% 和 81.4%。
- 风险调整分析中,PCI 和 CABG 在 1 年和 3 年时的 SAQ-SS 和 SAQ-AF 均高于保守治疗。
- CABG 在 1 年时的 SAQ-AF 高于 PCI(比值比 1.54 [95%CI 1.03, 2.31]),但 3 年时 SAQ-SS(比值比 1.11 [95%CI 0.78, 1.57])和 SAQ-AF(比值比 0.94 [95%CI 0.58, 1.54])无差异。
临床怎么用
- 对于慢性冠心病患者,PCI 和 CABG 均可改善 3 年健康状态,优于保守治疗。
- CABG 在 1 年时心绞痛缓解优于 PCI,但 3 年时两者效果相当。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: In ISCHEMIA (International Study of Comparative Health Effectiveness With Medical and Invasive Approaches), an invasive strategy demonstrated better health status outcomes than a conservative strategy in patients with chronic coronary disease (CCD). Some previous studies have shown greater health status benefits with coronary artery bypass grafting (CABG) than percutaneous coronary intervention (PCI). Whether the health status benefits of invasive management in ISCHEMIA were driven primarily by participants treated with CABG is unknown. METHODS: The aim of this analysis was to describe the health status outcomes of participants treated with a conservative strategy (n=2232) compared with invasively managed participants treated with PCI (n=1198) or CABG (n=340) in ISCHEMIA. The Seattle Angina Questionnaire-7 summary score (SAQ-SS) and angina frequency score (SAQ-AF) were the primary outcomes, with higher scores indicating better health status. Proportional odds models comparing 1- and 3-year outcomes were fit, adjusting for demographic, clinical, and angiographic characteristics. RESULTS: SAQ-SS in the conservative, PCI, and CABG groups increased by 9.9±18.1, 15.7±19.3, and 16.1±19.1 points at 1 year and 11.5±20.2, 16.5±21.8, and 15.0±19.4 points at 3 years, respectively. Freedom from angina in the conservative, PCI, and CABG groups was noted in 61.4%, 73.3%, and 82.4% at 1 year and 70.4%, 76.1%, 81.4% at 3 years, respectively. In risk-adjusted analyses, PCI and CABG were each associated with a higher SAQ-SS and SAQ-AF at 1 and 3 years compared with conservative management. SAQ-AF was higher with CABG than PCI at 1 year (odds ratio, 1.54 [95% CI, 1.03, 2.31]), but no differences between CABG and PCI were observed in SAQ-SS (odds ratio, 1.11 [95% CI, 0.78, 1.57]) or SAQ-AF (odds ratio, 0.94 [95% CI, 0.58, 1.54]) at 3 years. CONCLUSIONS: In ISCHEMIA, both PCI and CABG were associated with better 3-year health status than conservative management. Better angina relief with CABG than PCI was seen at 1, but not 3, years. REGISTRATION: URL: https://www.clinicaltrials.gov; Unique identifier: NCT01471522.
引用
- Huded CP, Spertus JA, Jones PG, et al. Health Status Outcomes With Percutaneous Coronary Intervention and Coronary Artery Bypass Grafting in ISCHEMIA. Circulation. 2025. PMID: 40910165. doi:10.1161/CIRCULATIONAHA.125.073591
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。